3SBio Stock Price, News & Analysis (NASDAQ:SSRX)

$16.59 0.00 (0.00 %)
(As of 12/14/2017 04:00 PM ET)
Previous Close$16.59
Today's RangeN/A
52-Week Range$10.15 - $16.70
VolumeN/A
Average Volume149,084 shs
Market Capitalization$366.10 million
P/E RatioN/A
Dividend YieldN/A
Beta1.46

About 3SBio (NASDAQ:SSRX)

3SBio logo3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub.

Receive SSRX News and Ratings via Email

Sign-up to receive the latest news and ratings for SSRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biopharmaceuticals
Sub-IndustryN/A
SectorBiopharmaceuticals
SymbolNASDAQ:SSRX
CUSIPN/A
Phone+86-24-25811820

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

3SBio (NASDAQ:SSRX) Frequently Asked Questions

What is 3SBio's stock symbol?

3SBio trades on the NASDAQ under the ticker symbol "SSRX."

How were 3SBio's earnings last quarter?

3SBio Inc (NASDAQ:SSRX) announced its earnings results on Monday, March, 18th. The biotechnology company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by $0.02. The biotechnology company had revenue of $26.30 million for the quarter, compared to analysts' expectations of $25.63 million. View 3SBio's Earnings History.

Who are some of 3SBio's key competitors?

Who are 3SBio's key executives?

3SBio's management team includes the folowing people:

  • Jing Lou, Executive Chairman of the Board, Chief Executive Officer (Age 54)
  • Bo Tan, Chief Financial Officer, Executive Vice President, Executive Director (Age 44)
  • Fei You, Director - Finance (Age 38)
  • Weihonghas Xiao, Chief Operating Officer (Age 48)
  • Dongmei Su, Senior Vice President, Executive Director (Age 46)
  • Zhenping Zhu MD. Ph.D., Chief Scientific Officer, President - Research & Development (Age 52)
  • Bin Huang, Vice President, Executive Director (Age 56)
  • Xin Ma, Vice President - Human Resources (Age 51)
  • Yongfu Chen, Vice President (Age 60)
  • Kevin Liu, Vice President (Age 47)

How do I buy 3SBio stock?

Shares of 3SBio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 3SBio's stock price today?

One share of 3SBio stock can currently be purchased for approximately $16.59.

How big of a company is 3SBio?

3SBio has a market capitalization of $366.10 million.

How can I contact 3SBio?

3SBio's mailing address is No. 3 A1, Road 10 Shenyang Economy & Technology Development Zone, SHENYANG, LIA 110027, China. The biotechnology company can be reached via phone at +86-24-25811820.


MarketBeat Community Rating for 3SBio (SSRX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  85
MarketBeat's community ratings are surveys of what our community members think about 3SBio and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

3SBio (NASDAQ:SSRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

3SBio (NASDAQ:SSRX) Consensus Price Target History

Price Target History for 3SBio (NASDAQ:SSRX)

3SBio (NASDAQ:SSRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/20/2017Goldman Sachs GroupUpgradeNeutral -> BuyLowView Rating Details
(Data available from 12/14/2015 forward)

Earnings

3SBio (NASDAQ:SSRX) Earnings History and Estimates Chart

Earnings by Quarter for 3SBio (NASDAQ:SSRX)

3SBio (NASDAQ SSRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/18/2013Q4 2012$0.14$0.12$25.63 million$26.30 millionViewListenView Earnings Details
11/12/2012Q312$0.29$0.15$28.18 million$28.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

3SBio (NASDAQ:SSRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for 3SBio (NASDAQ:SSRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for 3SBio (NASDAQ SSRX)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

3SBio (NASDAQ SSRX) News Headlines

Source:
DateHeadline
Financial Comparison: 3SBio (SSRX) vs. Its CompetitorsFinancial Comparison: 3SBio (SSRX) vs. Its Competitors
www.americanbankingnews.com - December 3 at 7:30 PM
Contrasting 3SBio (SSRX) & Its CompetitorsContrasting 3SBio (SSRX) & Its Competitors
www.americanbankingnews.com - November 23 at 3:12 PM
Financial Review: 3SBio (SSRX) versus Its RivalsFinancial Review: 3SBio (SSRX) versus Its Rivals
www.americanbankingnews.com - November 6 at 9:25 AM
3SBio (SSRX) and Its Rivals Head-To-Head Survey3SBio (SSRX) and Its Rivals Head-To-Head Survey
www.americanbankingnews.com - November 4 at 1:22 PM

SEC Filings

3SBio (NASDAQ:SSRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

3SBio (NASDAQ:SSRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

3SBio (NASDAQ SSRX) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.